Curis | CRIS - Процентные расходы





Процентные расходы Изменить Дата
Alaunos Therapeutics USD 1.07M 215K 2023-06
Amgen USD 657M 4M 2026-03
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
CSL USD 215M 111M 2025-12
Curis USD 178K 441K 2023-12
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 240M 15M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Incyte USD 569K 13K 2026-03
Merck USD 479M 67M 2026-03
Novartis USD 343M 39M 2026-03
Pfizer USD 671M 40M 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
Takeda JPY 43.65B 79.98B 2026-03
TG Therapeutics USD 7.67M 1.13M 2026-03
Verastem USD 415K 733K 2025-12
Xoma USD 3.4M 150K 2024-06